Collegium Pharmaceutical (354) Hedge Fund Trading Activity
Trend: ▲ Hedge Funds Increased Holdings by 797.4K Shares Last Quarter
Hedge Fund Holdings in 354
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
 Kenneth Tropin | Graham Capital Management, L.P. | New | 100.00% | $323,637 | <0.01% | ||
 Martin Whitman | Third Avenue Management LLC | Not Changed | 0.00% | $9,417,466 | 1.71% | ||
 Joel Greenblatt | Gotham Asset Management LLC | Not Changed | 0.00% | $1,299,826 | 0.01% | ||
 Chuck Royce | Royce & Associates LLC | Reduced | -17.96% | $11,628,383 | 0.12% |
FAQ
Which hedge funds hold Collegium Pharmaceutical?
The hedge funds that hold the most shares in Collegium Pharmaceutical are Chuck Royce, Martin Whitman and Joel Greenblatt.
Are hedge funds buying or selling DE:354?
In the last quarter hedge funds have Increased their holdings in Collegium Pharmaceutical by 797.4K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Collegium Pharmaceutical stock?
Warren Buffet currently does not own shares in Collegium Pharmaceutical.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here